APTINYX INC's ticker is APTX and the CUSIP is 03836N103. A total of 50 filers reported holding APTINYX INC in Q3 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $134 | -98.7% | 462 | -98.3% | 0.00% | – |
| Q3 2022 | $10,000 | +150.0% | 27,395 | +1332.0% | 0.00% | – |
| Q3 2021 | $4,000 | 0.0% | 1,913 | +36.3% | 0.00% | – |
| Q2 2021 | $4,000 | -85.7% | 1,404 | -84.7% | 0.00% | – |
| Q1 2021 | $28,000 | -9.7% | 9,180 | +0.9% | 0.00% | – |
| Q4 2020 | $31,000 | +675.0% | 9,097 | +726.2% | 0.00% | – |
| Q3 2020 | $4,000 | -87.9% | 1,101 | -86.1% | 0.00% | – |
| Q2 2020 | $33,000 | +3200.0% | 7,947 | +2549.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -87.5% | 300 | -86.7% | 0.00% | – |
| Q3 2019 | $8,000 | +100.0% | 2,259 | +105.4% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -76.5% | 1,100 | +10.0% | 0.00% | – |
| Q4 2018 | $17,000 | -75.7% | 1,000 | -59.1% | 0.00% | – |
| Q3 2018 | $70,000 | – | 2,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,290,079 | $1,836,000 | 1.19% |
| ADAMS STREET PARTNERS LLC | 5,395,996 | $3,010,000 | 0.78% |
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $4,961,000 | 0.58% |
| Artal Group S.A. | 6,116,493 | $3,412,000 | 0.18% |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $1,051,000 | 0.10% |
| NORTHWESTERN UNIVERSITY | 109,280 | $61,000 | 0.06% |
| DCF Advisers, LLC | 48,529 | $27,000 | 0.02% |
| Meridian Wealth Management, LLC | 192,000 | $107,000 | 0.01% |
| Orbimed Advisors | 538,500 | $300,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 157,641 | $88,000 | 0.00% |